Literature DB >> 18215145

Quantification of PtdIns(3,4,5)P(3) dynamics in EGF-stimulated carcinoma cells: a comparison of PH-domain-mediated methods with immunological methods.

Shu-Chin Yip1, Robert J Eddy, Angie M Branch, Huan Pang, Haiyan Wu, Ying Yan, Beth E Drees, Paul O Neilsen, John Condeelis, Jonathan M Backer.   

Abstract

Class IA PI3Ks (phosphoinositide 3-kinases) generate the secondary messenger PtdIns(3,4,5)P(3), which plays an important role in many cellular responses. The accumulation of PtdIns(3,4,5)P(3) in cell membranes is routinely measured using GFP (green fluorescent protein)-labelled PH (pleckstrin homology) domains. However, the kinetics of membrane PtdIns(3,4,5)P(3) synthesis and turnover as detected by PH domains have not been validated using an independent method. In the present study, we measured EGF (epidermal growth factor)-stimulated membrane PtdIns(3,4,5)P(3) production using a specific monoclonal anti-PtdIns(3,4,5)P(3) antibody, and compared the results with those obtained using PH-domain-dependent methods. Anti-PtdIns(3,4,5)P(3) staining rapidly accumulated at the leading edge of EGF-stimulated carcinoma cells. PtdIns(3,4,5)P(3) levels were maximal at 1 min, and returned to basal levels by 5 min. In contrast, membrane PtdIns(3,4,5)P(3) production, measured by the membrane translocation of an epitope-tagged (BTK)PH (PH domain of Bruton's tyrosine kinase), remained approx. 2-fold above basal level throughout 4-5 min of EGF stimulation. To determine the reason for this disparity, we measured the rate of PtdIns(3,4,5)P(3) hydrolysis by measuring the decay of the PtdIns(3,4,5)P(3) signal after LY294002 treatment of EGF-stimulated cells. LY294002 abolished anti-PtdIns(3,4,5)P(3) membrane staining within 10 s of treatment, suggesting that PtdIns(3,4,5)P(3) turnover occurs within seconds of synthesis. In contrast, (BTK)PH membrane recruitment, once initiated by EGF, was relatively insensitive to LY294002. These data suggest that sequestration of PtdIns(3,4,5)P(3) by PH domains may affect the apparent kinetics of PtdIns(3,4,5)P(3) accumulation and turnover; consistent with this hypothesis, we found that GRP-1 (general receptor for phosphoinositides 1) PH domains [which, like BTK, are specific for PtdIns(3,4,5)P(3)] inhibit PTEN (phosphatase and tensin homologue deleted on chromosome 10) dephosphorylation of PtdIns(3,4,5)P(3) in vitro. These data suggest that anti-PtdIns(3,4,5)P(3) antibodies are a useful tool to detect localized PtdIns(3,4,5)P(3), and illustrate the importance of using multiple approaches for the estimation of membrane phosphoinositides.

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 18215145      PMCID: PMC2915465          DOI: 10.1042/BJ20071179

Source DB:  PubMed          Journal:  Biochem J        ISSN: 0264-6021            Impact factor:   3.857


  35 in total

1.  Exploring the specificity of the PI3K family inhibitor LY294002.

Authors:  Severine I Gharbi; Marketa J Zvelebil; Stephen J Shuttleworth; Tim Hancox; Nahid Saghir; John F Timms; Michael D Waterfield
Journal:  Biochem J       Date:  2007-05-15       Impact factor: 3.857

2.  Selective cellular effects of overexpressed pleckstrin-homology domains that recognize PtdIns(3,4,5)P3 suggest their interaction with protein binding partners.

Authors:  Péter Várnai; Tzvetanka Bondeva; Péter Tamás; Balázs Tóth; László Buday; László Hunyady; Tamas Balla
Journal:  J Cell Sci       Date:  2005-10-15       Impact factor: 5.285

Review 3.  Probing phosphoinositide functions in signaling and membrane trafficking.

Authors:  C Peter Downes; Alex Gray; John M Lucocq
Journal:  Trends Cell Biol       Date:  2005-05       Impact factor: 20.808

4.  PIP2 signaling in lipid domains: a critical re-evaluation.

Authors:  Jacco van Rheenen; Eskeatnaf Mulugeta Achame; Hans Janssen; Jero Calafat; Kees Jalink
Journal:  EMBO J       Date:  2005-04-21       Impact factor: 11.598

5.  Specific requirement for the p85-p110alpha phosphatidylinositol 3-kinase during epidermal growth factor-stimulated actin nucleation in breast cancer cells.

Authors:  K Hill; S Welti; J Yu; J T Murray; S C Yip; J S Condeelis; J E Segall; J M Backer
Journal:  J Biol Chem       Date:  2000-02-11       Impact factor: 5.157

6.  Role of substrates and products of PI 3-kinase in regulating activation of Rac-related guanosine triphosphatases by Vav.

Authors:  J Han; K Luby-Phelps; B Das; X Shu; Y Xia; R D Mosteller; U M Krishna; J R Falck; M A White; D Broek
Journal:  Science       Date:  1998-01-23       Impact factor: 47.728

7.  Regulation of GRP1-catalyzed ADP ribosylation factor guanine nucleotide exchange by phosphatidylinositol 3,4,5-trisphosphate.

Authors:  J K Klarlund; L E Rameh; L C Cantley; J M Buxton; J J Holik; C Sakelis; V Patki; S Corvera; M P Czech
Journal:  J Biol Chem       Date:  1998-01-23       Impact factor: 5.157

Review 8.  Inositol-lipid binding motifs: signal integrators through protein-lipid and protein-protein interactions.

Authors:  Tamas Balla
Journal:  J Cell Sci       Date:  2005-05-15       Impact factor: 5.285

9.  The distinct roles of Ras and Rac in PI 3-kinase-dependent protrusion during EGF-stimulated cell migration.

Authors:  Shu-Chin Yip; Mirvat El-Sibai; Salvatore J Coniglio; Ghassan Mouneimne; Robert J Eddy; Beth E Drees; Paul O Neilsen; Sumanta Goswami; Marc Symons; John S Condeelis; Jonathan M Backer
Journal:  J Cell Sci       Date:  2007-08-14       Impact factor: 5.285

10.  Localization of agonist-sensitive PtdIns(3,4,5)P3 reveals a nuclear pool that is insensitive to PTEN expression.

Authors:  Yvonne Lindsay; David McCoull; Lindsay Davidson; Nick R Leslie; Alison Fairservice; Alex Gray; John Lucocq; C Peter Downes
Journal:  J Cell Sci       Date:  2006-12-15       Impact factor: 5.285

View more
  19 in total

1.  Inducible knockout of GRP78/BiP in the hematopoietic system suppresses Pten-null leukemogenesis and AKT oncogenic signaling.

Authors:  Shiuan Wey; Biquan Luo; Chun-Chih Tseng; Min Ni; Hui Zhou; Yong Fu; Deepa Bhojwani; William L Carroll; Amy S Lee
Journal:  Blood       Date:  2011-09-21       Impact factor: 22.113

2.  Quantification and visualization of phosphoinositides by quantum dot-labeled specific binding-domain probes.

Authors:  Yasuhiro Irino; Emi Tokuda; Junya Hasegawa; Toshiki Itoh; Tadaomi Takenawa
Journal:  J Lipid Res       Date:  2012-02-03       Impact factor: 5.922

3.  Regulation of Class IA PI 3-kinases: C2 domain-iSH2 domain contacts inhibit p85/p110alpha and are disrupted in oncogenic p85 mutants.

Authors:  Haiyan Wu; S Chandra Shekar; Rory J Flinn; Mirvat El-Sibai; Bijay S Jaiswal; K Ilker Sen; Vasantharajan Janakiraman; Somasekar Seshagiri; Gary J Gerfen; Mark E Girvin; Jonathan M Backer
Journal:  Proc Natl Acad Sci U S A       Date:  2009-11-13       Impact factor: 11.205

4.  Live-cell fluorescence microscopy with molecular biosensors: what are we really measuring?

Authors:  Jason M Haugh
Journal:  Biophys J       Date:  2012-05-02       Impact factor: 4.033

5.  Phosphorylation of CSF-1R Y721 mediates its association with PI3K to regulate macrophage motility and enhancement of tumor cell invasion.

Authors:  Natalia G Sampaio; Wenfeng Yu; Dianne Cox; Jeffrey Wyckoff; John Condeelis; E Richard Stanley; Fiona J Pixley
Journal:  J Cell Sci       Date:  2011-05-24       Impact factor: 5.285

6.  Profilin1 regulates PI(3,4)P2 and lamellipodin accumulation at the leading edge thus influencing motility of MDA-MB-231 cells.

Authors:  Yong Ho Bae; Zhijie Ding; Tuhin Das; Alan Wells; Frank Gertler; Partha Roy
Journal:  Proc Natl Acad Sci U S A       Date:  2010-11-29       Impact factor: 11.205

7.  A compartmentalized phosphoinositide signaling axis at cilia is regulated by INPP5E to maintain cilia and promote Sonic Hedgehog medulloblastoma.

Authors:  S E Conduit; V Ramaswamy; M Remke; D N Watkins; B J Wainwright; M D Taylor; C A Mitchell; J M Dyson
Journal:  Oncogene       Date:  2017-06-26       Impact factor: 9.867

8.  Lipid biosensor interactions with wild type and matrix deletion HIV-1 Gag proteins.

Authors:  Eric Barklis; August O Staubus; Andrew Mack; Logan Harper; Robin Lid Barklis; Ayna Alfadhli
Journal:  Virology       Date:  2018-03-15       Impact factor: 3.616

9.  Differential enhancement of breast cancer cell motility and metastasis by helical and kinase domain mutations of class IA phosphoinositide 3-kinase.

Authors:  Huan Pang; Rory Flinn; Antonia Patsialou; Jeffrey Wyckoff; Evanthia T Roussos; Haiyan Wu; Maria Pozzuto; Sumanta Goswami; John S Condeelis; Anne R Bresnick; Jeffrey E Segall; Jonathan M Backer
Journal:  Cancer Res       Date:  2009-11-10       Impact factor: 12.701

10.  Idelalisib Impacts Cell Growth through Inhibiting Translation-Regulatory Mechanisms in Mantle Cell Lymphoma.

Authors:  Qingshan Yang; Lisa S Chen; Min Jin Ha; Kim-Anh Do; Sattva S Neelapu; Varsha Gandhi
Journal:  Clin Cancer Res       Date:  2016-06-24       Impact factor: 12.531

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.